Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 9Unknown 6Terminated 4Withdrawn 1

Sponsor Class

NIH 5NETWORK 1

Study Type

Observational 5Interventional 1

Sponsor

Cancer Type

Breast 6Other hematologic neoplasm 3Gynecologic 2Gastrointestinal 2Sarcoma 1Head & Neck 1Dermatologic 1

Conditions

Breast Neoplasms 6

Interventions

Capecitabine 88Cyclophosphamide 87Trastuzumab 81Docetaxel 81Paclitaxel 65pyrotinib 55Epirubicin 55Tamoxifen 53Letrozole 51Fulvestrant 48Vinorelbine 43Carboplatin 42Doxorubicin 41Radiotherapy 33exemestane 31Anastrozole 31Neoadjuvant Therapy 29palbociclib 27Drug Therapy 27Fluorouracil 24Bevacizumab 24pertuzumab 23Cisplatin 23eribulin 22130-nm albumin-bound paclitaxel 21Goserelin 20Gemcitabine 20Exercise 20Chemotherapy, Adjuvant 19liposomal doxorubicin 17

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Unknown × Microarray Analysis × Breast × Clear all
NCT01004796 2016-02-29

Study of Biomarkers in Tissue Samples From Patients With Breast Cancer

National Cancer Institute (NCI)

Unknown
Breast

Breast Neoplasms

NCT01420185 2015-05-08

Identification of Genes That Predict Local Recurrence in Samples From Patients With Breast Cancer Treated on NSABP-B-28

NSABP Foundation Inc

Unknown
1,300 enrolled
Breast

Breast Neoplasms

NCT00463034 2013-12-18

Genes That Affect Disease Progression in Women With Newly Diagnosed or Metastatic Breast Cancer

National Cancer Institute (NCI)

Unknown
1,800 enrolled
Breast

Breast Neoplasms

NCT00898690 2013-12-18

Gene Expression in Predicting Response to Paclitaxel in Patients With Breast Cancer

National Cancer Institute (NCI)

Unknown
120 enrolled
Breast

Breast Neoplasms

NCT00070278 2013-08-07

Neoadjuvant Epirubicin, Cyclophosphamide, and Paclitaxel With or Without Gemcitabine in Treating Women Who Are Undergoing Surgery for Early Breast Cancer

National Cancer Institute (NCI)

Phase 3 Unknown
800 enrolled
Breast

Breast Neoplasms

NCT00897065 2013-07-10

Biomarkers in Predicting Response to Tamoxifen and Letrozole in Postmenopausal Women With Primary Breast Cancer Treated on Clinical Trial CAN-NCIC-MA17

National Cancer Institute (NCI)

Unknown
957 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡